Kairos Pharma (KAPA) Enterprise Value (2023 - 2025)
Kairos Pharma's (KAPA) quarterly Enterprise Value came in at -$4.5 million in Q4 2025, down 253.07% YoY from $2.9 million in Q4 2024, and down 48.02% on a QoQ basis from -$3.0 million in Q2 2025.
Kairos Pharma (KAPA) Enterprise Value (2023 - 2025) Analysis & Trends
Kairos Pharma (KAPA) has 3 years of Enterprise Value data on file, last reported at -$4.5 million in Q4 2025.
- Quarterly Enterprise Value fell 253.07% year-over-year to -$4.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.5 million (down 253.07% YoY) and the FY2025 annual result came in at -$4.5 million, down 253.07% from the prior year.
- Enterprise Value declined to -$4.5 million in Q4 2025, from -$3.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$3504.0 in Q1 2025 to a low of -$4.5 million in Q4 2025.
- A 3-year average of -$1.7 million and a median of -$1.3 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value sank 3149.49% — and 2025, when it sank 253.07%.
- Tracing KAPA's Enterprise Value over 3 years: stood at -$93000.0 in 2023, then sank by 1267.74% to -$1.3 million in 2024, then slumped by 253.07% to -$4.5 million in 2025.
- The last three Enterprise Value figures came in at -$4.5 million (Q4 2025), -$3.0 million (Q2 2025), and -$3504.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 2.12 Bn |
| 10 | Kairos Pharma | 5.46 Mn | 124,153.18 | - | -5.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.49 Mn |
| Jun 30, 2025 | -3.03 Mn |
| Mar 31, 2025 | -3,504.00 |
| Dec 31, 2024 | -1.27 Mn |
| Sep 30, 2024 | -3.22 Mn |
| Dec 31, 2023 | -93,000.00 |
| Sep 30, 2023 | -99,000.00 |